Identification and optimisation of a series of 8-hydroxy naphthyridines with potent in vitro antileishmanial activity: Initial SAR and assessment of in vivo activity.

Visceral leishmaniasis (VL) is a parasitic infection that results in approximately 26,000 – 65,000 deaths annually. The available treatments are hampered by issues such as toxicity, variable effica...